(S)-4-benzyl-3-(2-methoxyacetyl)oxazolidin-2-one, 97%, 5g

1-(2,5-Dichloropyridin-4-yl)ethanone, 95%, 1g

(Benzhydrylthio)acetic Acid>98.0%(GC)(T)5g

(1-PROPYL-1H-IMIDAZOL-5-YL)METHANOL, 95.0%, 1g

Methyl 6-fluoro-1H-indole-2-carboxylate, 95.0%, 500mg

Lámina de molibdeno 99,9+% 0,025 x 150 x 150 mm 1 ud.

Nitrato de cadmio tetrahidratado, mínimo 99 %, pa, 250 g, envase de vidrio

2-([1,1'-Biphenyl]-4-yl)-6-fluoroquinoline-4-carboxylic acid, 98%, 100mg

2-methyl-1H,2H,3H,4H,9H-pyrido[3,4-b]indole, 95.0%, 250mg

[(4-propyl-4H-1,2,4-triazol-3-yl)methyl]amine dihydrochloride, 95.0%, 1g

CLINAFLOXACIN, 95%, 250mg

4-Aminotetrahydrofuran-3-ol, 95.0%, 1g

4-Iodo-2,2-dimethyltetrahydro-2H-pyran, 97%, 10g